BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:America/Phoenix X-WR-TIMEZONE:America/Phoenix BEGIN:VEVENT UID:1675@azbio.org DTSTART;TZID=America/Phoenix:20220517T080000 DTEND;TZID=America/Phoenix:20220517T090000 DTSTAMP:20220322T155658Z URL:https://www.azbio.org/events/azbiopeers-thinking-about-an-sbir-or-sttr -how-to-access-non-dilutive-capital-for-small-businesses-part-2-listening- to-people-that-were-successful SUMMARY:AZBioPEERS: “Thinking about an SBIR or STTR? How to access Non-Di lutive capital for small businesses” Part 2: Listening to people that w ere successful. - - 17 May 22 08:00 DESCRIPTION:\nThinking about an SBIR or STTR? \nHow to access Non-Dilutive capital for small businesses\, Part 2: Listening to people that were succ essful.\nTuesday\, May 17th\, 2022   08:00 – 09:00 AM\n\nFeatured Speak ers:\n\n Dr. Evan Unger -  Co-Founder\, CEO\, and President of NuvOx Pha rma   (Received 9 SBIR/STTRs)\n Dave Talenfeld\, JD MBA MGM - CEO Bota nisol Analytics\, Inc. (Received 3 SBIR/STTR\, including DoD)\n \nDr. Eri ca Forzani - Associate Professor\, \nBiodesign Institute's Center for B ioelectronics &\; Biosensors\, Health Future Center's ASU-Mayo Clinic\,  Co-Founder of Breezing Corp. &\; Sequitur Health Corp. (Received 8 S BIR/STTR)\n Sonia Vohnout - Founder &\; President\, OppSpot\, LLC\n\n Please join us as a panel of Life-Science entrepreneurs discuss their expe riences writing successful SBIR and STTR grants.\n\n \;\n\nLocation:  Virtual via Zoom\n\n \;\nREGISTER\nAbout Our Speakers\n \;\n\nDr . Evan Unger -  Co-Founder\, CEO\, and President of NuvOx Pharma\n\n\n\nD r. Evan Unger is Co-Founder\, Chief Executive Officer\, and President of N uvOx Pharma\, a\nclinical stage biotechnology company with Phase II progra ms in brain cancer and ischemic\nstroke. Dr. Unger has founded four biotec hnology companies. His first company\, ImaRx\nPharmaceutical\, developed 3 FDA approved drugs and was acquired by DuPont yielding a >\; 20x\nROI. ImaRx Pharmaceutical developed Definity®\, the world’s #1 selling ultra sound contrast\nagent\, marketed by Lantheus. About 60% of Lantheus sales are due to Definity (Lantheus\nmarket cap ~ $2B). When Dr. Unger sold ImaR x Pharmaceutical to DuPont\, he retained the\ntherapeutic rights to Defini ty (perfluoropropane microbubbles) and launched his second\ncompany\, ImaR x Therapeutics\, which went public and performed clinical trials using a\n pioneering new technology - microbubbles with ultrasound (sonothrombolysis ) to treat ischemic stroke. Based upon his pioneering work on microbubble s\, Dr. Unger discovered that microbubbles carry far more oxygen than liq uids. Therefore\, Dr. Unger co-founded NuvOx to develop NanO2TM\, based u pon nanobubbles\, the world’s most effective oxygen therapeutic.\nNanO2 has completed Phase Ib/II clinical trials in brain cancer as a radiosensit izer and in stroke as a neuroprotectant\, showing safety and efficacy in both indications. Dr. Unger also founded Microvascular Therapeutics\, a c ompany that is developing a new\, improved ultrasound contrast agent via the 505(b)(2) pathway and theranostic products. Dr. Unger is inventor on o ver 120\nissued US patents. He is a board-certified radiologist and is Pro fessor Emeritus of Medical Imaging at the University of Arizona. He is au thor on at least 140 peer reviewed publications and has served as Member and Ad-Hoc Member of multiple study NIH study sections. Dr. Unger complet ed his residency in diagnostic radiology at the Washington University St. Louis. He graduated Alpha Omega Alpha from the University of California a t San Francisco School of Medicine. Dr. Unger received a BA from UC Berke ley with Departmental Honors in Economics.\n\n \;\n\nDave Talenfeld\, JD MBA MGM\, CEO Botanisol Analytics\, Inc.\n\n\n\nDave is a three time life science entrepreneur and expert on leveraging government and military financing to develop technologies for both defense and private sector use . He’s a Flinn Foundation Bioscience Entrepreneurship Award Recipient\, an Armed Forces Communications and Electronics Association 40 under 40\, a n Arizona BioIndustry Association Fastlane Awardee\, a TEDmed frontline Sc holar\, an Exponential Medicine MEDy award recipient\, and a graduate of t he Air Force Accelerator Powered by Techstars. He’s raised $16.3 million in venture capital from 10 US states\, Canada\, India\, the United Arab E mirates and Singapore while working with suppliers and joint venture partn ers in Portugal and Holland\, Namibia\, and Qatar.\nHis career has emphasi zed medical technology development including roles with the University of Arizona Office of Technology Transfer and Office of University Research Pa rks\, consulting engagements with Los Alamos National Laboratories and the CORE Institute\, legal clerkships emphasizing issues pertaining to the co rporate practice of medicine\, market\, technology\, and regulatory resear ch for a provider of healthcare market research\, and investment diligence for the leading medical technology investment organization in the Southwe stern United States. He holds an MBA in the marketing of innovation from t he Eller College of Management\, a JD emphasizing comparative commercial l aw from the Rogers College of Law at the University of Arizona and an MGM from the Thunderbird School of Global Management at Arizona State Universi ty with a focus on international entrepreneurship including European and L atin American regional business environments.\n\nAfter his last company wa s sold for $22\,000\,000 he turned his attention to Botanisol Analytics\, which makes the world’s first Autonomous Disease Detection Kiosks. The c ompany has been awarded contracts with the Air Force Research Laboratory\, Applied Technology and Genomics Division Biosurveillance Unit\, and the A ir National Guard\, while completing a clinical validation with Harvard Be th Israel Deaconess Medical Center.\n\n \;\n\nDr. Erica Forzani\, Co-F ounder of Breezing Corp. &\; Sequitur Health Corp.\n\n\n\nErica Forzani  is Associate Professor in the Ira A. Fulton Schools of Engineering in Ar izona State University (ASU)\, Director of ASU – Mayo Clinic Medical Dev ices and Methods Laboratory at ASU’s Health Futures Center\, and Deputy Director of the Center for Bioelectronics &\; Biosensors at ASU’s Bi odesign Institute\, ASU Entrepreneur Professor\, ASU PluS Alliance Fellow on Global Health\, and Mayo Clinic’s Research Associate.\n\nHer interest s are the development of novel hybrid sensors and their integration into wireless\, passive and inexpensive devices. She has over 90+ peer-reviewed publications\, 10 patents\, 12 patent applications and 3 transferred inte llectual properties. She is also senior member of the National Academy of Inventors.\n\nWith a background in Clinical Chemistry\, Chemistry\, Engin eering\, and a passion in Lifestyle Behavioral Sciences\, Erica directs h er research\, professional\, and personal goals to bring new inspired-use technologies to real-world applications for health\, environment and safe ty. \n\nShe is co-founder of Breezing Co\, a company commercializing brea th analyzers and smart sensors\, and Sequitur Co\, a company developing po int-of-care solutions for urine and blood. Breezing was co-funded with lat e Dr. NJ Tao\, serial entrepreneur and professor @ASU\, and Sequitur was c o-funded with Dr. Leslie Thomas\, MD @ Mayo Clinic\, and Dr. Marylaura Tho mas\, Ph.D.\, professor @ ASU.\n\nDr. Forzani has been for 2 consecutive S ummers a Faculty Resident at Mayo Clinic\, Rochester\, and works with seve ral collaborators at Mayo Clinic. You can find more details about Erica F orzani here.\n\n \;\n\nSonia Vohnout - Founder &\; President\, Opp Spot\, LLC\n\n\n\n \;\n\nSonia has held executive management and senio r technical positions and has also co-founded several companies. She has o ver 30 years of experience in systems engineering\, quality systems\, busi ness development and program management.\n\nHer expertise in the SBIR/STTR program and consulting services to assist small business with this and ot her government funding vehicles have helped start-ups and small businesses raise tens of millions of dollars of federal funding. Sonia has a B.S and M.S in Systems Engineering from the University of Arizona. CATEGORIES:AZ - Central END:VEVENT BEGIN:VTIMEZONE TZID:America/Phoenix X-LIC-LOCATION:America/Phoenix BEGIN:STANDARD DTSTART:20210517T080000 TZOFFSETFROM:-0700 TZOFFSETTO:-0700 TZNAME:MST END:STANDARD END:VTIMEZONE END:VCALENDAR